BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33678326)

  • 1. The mechanism of anticancer activity of the new synthesized compound - 6,7-Methylenedioxy-4-(2,4-dimethoxyphenyl)quinolin -2(1H)-one(12e) in human ovarian cancer cell lines.
    Chan HC; Liao YH; Chang HW; Liu CH
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):266-272. PubMed ID: 33678326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of 6,7-methylenedioxy-4-substituted phenylquinolin-2(1H)-one derivatives as novel anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase.
    Chen YF; Lin YC; Huang PK; Chan HC; Kuo SC; Lee KH; Huang LJ
    Bioorg Med Chem; 2013 Sep; 21(17):5064-75. PubMed ID: 23867385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells.
    Huang SM; Yang JS; Tsai SC; Chen MH; Hsu MH; Lin HY; Chou LC; Chinag JH; Lee KH; Huang LJ; Kuo SC
    Int J Oncol; 2011 May; 38(5):1357-64. PubMed ID: 21344160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effects of Pimaric acid is mediated via endoplasmic reticulum stress, caspase-dependent apoptosis, cell cycle arrest, and inhibition of cell migration in human ovarian cancer cells.
    Li W; Xuemei G; Yilin Z; Han W; Yajun H; Yi H; Zhongxiang Z
    Acta Biochim Pol; 2022 Mar; 69(1):245-250. PubMed ID: 35231164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daidzein exerts anticancer activity towards SKOV3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the Raf/MEK/ERK cascade.
    Hua F; Li CH; Chen XG; Liu XP
    Int J Mol Med; 2018 Jun; 41(6):3485-3492. PubMed ID: 29512690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells.
    Long F; Wang T; Jia P; Wang H; Qing Y; Xiong T; He M; Wang X
    Med Sci Monit; 2017 Jan; 23():571-579. PubMed ID: 28141785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and In Vitro/In Vivo Anti-Cancer Activities of Novel (20
    Dai X; Wu G; Zhang Y; Zhang X; Yin R; Qi X; Li J; Jiang T
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K/AKT pathway.
    Lin W; Ye H
    J BUON; 2020; 25(2):750-756. PubMed ID: 32521863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y; Mi C
    Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor properties of Coenzyme Q
    Hseu YC; Tsai TJ; Korivi M; Liu JY; Chen HJ; Lin CM; Shen YC; Yang HL
    Sci Rep; 2017 Aug; 7(1):8062. PubMed ID: 28808311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel synthetic 2-(3-methoxyphenyl)-6,7-methylenedioxoquinolin-4-one arrests the G2/M phase arrest via Cdc25c and induces apoptosis through caspase- and mitochondria-dependent pathways in TSGH8301 human bladder cancer cells.
    Hsu SC; Yu CC; Yang JS; Lai KC; Wu SH; Lin JJ; Kuo JH; Yang ST; Huang CC; Kuo SC; Chung JG
    Int J Oncol; 2012 Mar; 40(3):731-8. PubMed ID: 22021033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3, 3'-Dimethylquercetin Inhibits the Proliferation of Human Colon Cancer RKO Cells through Inducing G2/M Cell Cycle Arrest and Apoptosis.
    Wu J; Yi J; Wu Y; Chen X; Zeng J; Wu J; Peng W
    Anticancer Agents Med Chem; 2019; 19(3):402-409. PubMed ID: 30398122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate.
    Greenshields AL; Shepherd TG; Hoskin DW
    Mol Carcinog; 2017 Jan; 56(1):75-93. PubMed ID: 26878598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.
    Chen X; Gong L; Ou R; Zheng Z; Chen J; Xie F; Huang X; Qiu J; Zhang W; Jiang Q; Yang Y; Zhu H; Shi Z; Yan X
    Gynecol Oncol; 2016 Mar; 140(3):537-44. PubMed ID: 26704638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspidin BB, a phloroglucinol derivative, induces cell cycle arrest and apoptosis in human ovarian HO-8910 cells.
    Sun Y; Mu F; Li C; Wang W; Luo M; Fu Y; Zu Y
    Chem Biol Interact; 2013 Jul; 204(2):88-97. PubMed ID: 23628508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
    Chen T; Xu Y; Guo H; Liu Y; Hu P; Yang X; Li X; Ge S; Velu SE; Nadkarni DH; Wang W; Zhang R; Wang H
    PLoS One; 2011; 6(6):e20729. PubMed ID: 21673964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swerchirin exerts anticancer activity on SKOV3 human ovarian cancer cells via induction of mitochondrial apoptosis, G2/M cell cycle arrest and inhibition of Raf/MEK/ERK cascade.
    Luo L; Zhao H; Luo Q
    J BUON; 2018; 23(1):111-116. PubMed ID: 29552769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor effects of osthole on ovarian cancer cells in vitro.
    Jiang G; Liu J; Ren B; Tang Y; Owusu L; Li M; Zhang J; Liu L; Li W
    J Ethnopharmacol; 2016 Dec; 193():368-376. PubMed ID: 27566206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
    Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
    Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers.
    Tseng CH; Tzeng CC; Hsu CY; Cheng CM; Yang CN; Chen YL
    Eur J Med Chem; 2015 Jun; 97():306-19. PubMed ID: 26005780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.